Sort by:

select Language:


The Oxford Statement on Medicine Quality and Public Health


In September, 2018, the first international Medicine Quality and Public Health Conference was held at Oxford University, UK, to discuss opportunities and solutions to ensure that all people have access to affordable and quality-assured medical products. Delegates developed the short Oxford Statement, calling for investment, policy change, and action to eliminate substandard and falsified medical products. The statement was born out of discussion between governments, national and international agencies, non-governmental organisations, professional associations, and academic institutions who together examined the latest evidence on the epidemiology and public health implications of substandard and falsified medical products.

GPHF-Minilab: Manuals

Global Pharma Health Fund E.V., (2008)

GPHF Minilab manuals on basic dye and thin layer chromatographic testing. The newest version of the manual (Volume I + II) from 2008 is available in three languages: English, French, Spanish. Combining the main manual with the supplements issued each year between 2010 and 2015, label claims on drug identity and content can now be verified for 75 active ingredients and their fixed-dose combination products using simple, rapid and affordable thin layer chromatographic tests. Please note: Only the demo versions are online available!! The complete manuals are only available after purchasing the Minilab!

Alerte Produit Médical N° 4/2016 Quinine Sulfate falsifiée circulant en Afrique de l’Ouest et en Afrique Centrale

Organisation Mondiale de la Santé (OMS), (2016)

Cette Alerte fait référence à la circulation au Cameroun et en République Démocratique du Congo, de deux versions falsifiées confirmées de Quinine Sulfate, qui ne contiennent aucun principe actif.

Medical Product Alert N° 4/2016: Falsified Quinine Sulphate circulating in West and Central Africa

World Health Organization, (2016)

This Medical Product Alert relates to the recent circulation of two confirmed falsified versions of Quinine Sulphate circulating in Cameroon and the Democratic Republic of the Congo, containing zero active pharmaceutical ingredient

Regional Strategy on Regulation of Medical Products in the African Region, 2016–2025

World Health Organization, Regional Office for Africa , (2016)

Every day, fake medicines and medical products are sold at street corners, in open air markets or on unregulated websites in several countries in the African Region. These poor quality, unsafe medicines and pharmaceutical products promote drug resistance and lead to loss of confidence in health professionals, manufacturers and distributors and in health systems. In an effort to protect people’s health, the WHO Regional Director for Africa, Dr Matshidiso Moeti, has proposed a strategy aimed at strengthening National Medicine Regulatory Authorities (NMRAs) in order to ensure that only safe, good quality and effective medical products are available.

Étude sur les outils juridiques à la disposition des ordres de pharmaciens dans la lutte contre les médicaments falsifiés (Bénin, Burkina Faso, Guinée, Mali)

François Locher , Eds.: PUPH, Université Lyon1 (ISPB-Faculté de Pharmacie) et Hospices Civils de Lyon, (2015)

Dans le cadre du projet Tracmed, une étude sur les outils législatifs et juridiques à disposition des ordres des pharmaciens dans la lutte contre les médicaments falsifiés a été réalisée en juillet 2015. Cette étude porte sur le Bénin, le Burkina Faso, la Guinée et le Mali. Le document original peut être trouvé via le lien suivant:

The fight against fake drugs by NAFDAC in Nigeria

The fight against fake drugs by NAFDAC in Nigeria Olike Chinwendu , Eds.: KIT (Royal Tropical Institute) Development Policy & Practice/ Vrije Universiteit Amsterdam , (2008)

Review over the work and challenges of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) in combatting counterfeiting of medicines in Nigeria.

13 hits